|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
5.270 +0.020 (+0.381%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,224,064 | -48.216% | 2,363,780 | 2,437,956 | 1,887,652 | 1,550,044 |
| Cost of Sales | (1,047,965) | -50.912% | (2,134,849) | (2,219,866) | (1,710,708) | (1,431,562) |
| Gross Profit | 176,099 | -23.078% | 228,931 | 218,090 | 176,944 | 118,482 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,583) | -21.513% | (3,291) | (1,829) | (90,104) | (2,170,824) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (13,523) | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (58) | -63.057% | (157) | 0 | 81 | (342) | |
| Profit / (Loss) before Taxation | (82,369) | 9.593% | (75,159) | (86,698) | (344,441) | (2,516,810) | |
| Taxation | 1,230 | 142.126% | 508 | (609) | (1,546) | 38 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 9,154 | -- | (3,551) | (5,014) | (340) | 6,707 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (71,985) | -7.950% | (78,202) | (92,321) | (346,327) | (2,510,065) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (4,307) | -50.271% | (8,661) | (17,935) | (6,250) | (5,352) |
| Depreciation & Amortisation | 15,455 | -35.207% | 23,853 | 26,910 | 26,470 | 27,454 |
| Directors' Emoluments | -- | -- | -- | -- | 43,947 | 51,384 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | Unqualified | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -12.000 | 0.000% | -12.000 | -14.000 | -350.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.328 | -- | 1.962 | 2.371 | -- | -- |
| Remarks: | Real time quote last updated: 05/09/2025 11:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -71,985 |
| %Change | -7.950% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 1.328 |